Kyowa Kirin Co., Ltd. (4151.T)

JPY 2393.0

(0.46%)

Net Debt Summary of Kyowa Kirin Co., Ltd.

  • Kyowa Kirin Co., Ltd.'s latest annual net debt in 2023 was -378.83 Billion JPY , down -19.92% from previous year.
  • Kyowa Kirin Co., Ltd.'s latest quarterly net debt in 2024 Q1 was -313.97 Billion JPY , up 17.12% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported annual net debt of -315.91 Billion JPY in 2022, down -1.08% from previous year.
  • Kyowa Kirin Co., Ltd. reported annual net debt of -312.54 Billion JPY in 2021, down -16.3% from previous year.
  • Kyowa Kirin Co., Ltd. reported quarterly net debt of -296.33 Billion JPY for 2024 Q3, down -1.89% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported quarterly net debt of -313.97 Billion JPY for 2024 Q1, up 17.12% from previous quarter.

Annual Net Debt Chart of Kyowa Kirin Co., Ltd. (2023 - 1999)

Historical Annual Net Debt of Kyowa Kirin Co., Ltd. (2023 - 1999)

Year Net Debt Net Debt Growth
2023 -378.83 Billion JPY -19.92%
2022 -315.91 Billion JPY -1.08%
2021 -312.54 Billion JPY -16.3%
2020 -268.73 Billion JPY -10118.14%
2019 -2.63 Billion JPY 80.28%
2018 -13.33 Billion JPY -12.38%
2017 -11.87 Billion JPY -54.04%
2016 -7.7 Billion JPY 8.22%
2015 -8.39 Billion JPY 46.82%
2014 -15.78 Billion JPY -12.92%
2013 -13.98 Billion JPY 11.93%
2012 -15.87 Billion JPY 24.47%
2011 -21.02 Billion JPY 17.92%
2010 -25.61 Billion JPY -51.27%
2009 -16.93 Billion JPY 12.89%
2008 -19.43 Billion JPY -241.56%
2007 -5.69 Billion JPY 63.89%
2006 -15.75 Billion JPY -24.14%
2005 -12.69 Billion JPY 43.76%
2004 -22.57 Billion JPY -106.26%
2003 -10.94 Billion JPY -131.85%
2002 34.35 Billion JPY -17.58%
2001 41.68 Billion JPY -45.08%
2000 75.9 Billion JPY -19.17%
1999 93.89 Billion JPY 0.0%

Peer Net Debt Comparison of Kyowa Kirin Co., Ltd.

Name Net Debt Net Debt Difference
Astellas Pharma Inc. 670.02 Billion JPY 156.54%
Chugai Pharmaceutical Co., Ltd. -445.21 Billion JPY 14.91%
Ono Pharmaceutical Co., Ltd. -157.27 Billion JPY -140.869%
Santen Pharmaceutical Co., Ltd. -59.42 Billion JPY -537.513%
JCR Pharmaceuticals Co., Ltd. 4.54 Billion JPY 8437.06%
Daiichi Sankyo Company, Limited -259.26 Billion JPY -46.121%
Otsuka Holdings Co., Ltd. -299.15 Billion JPY -26.636%
Perseus Proteomics Inc. -1.54 Billion JPY -24477.094%